Skip to content

Clinical Efficacy and Safety of Fractional CO2 Laser Application at Different Time Points in the Early Postoperative Period for Preventing Scar Formation

Clinical Efficacy and Safety of Fractional CO2 Laser Application at Different Time Points in the Early Postoperative Period for Preventing Scar Formation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110709
Enrollment
Unknown
Registered
2025-10-20
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scar

Interventions

Experimental Group (Postoperative Week 1 Group):Fractional CO2 Laser Treatment
Control Group (Postoperative Month 1 Group):Fractional CO2 Laser Treatment

Sponsors

Peking University Shenzhen Hospital?
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary Participation and Informed Consent:??Individuals who voluntarily agree to participate in this clinical study and provide written informed consent. ?2. Age and Gender Criteria:??Male or female subjects aged between 18 and 70 years old (inclusive). ?3. Surgical Wound Condition:??Patients with a linear sutured incision following thyroid surgery, exhibiting complete wound edge re-epithelialization.

Exclusion criteria

Exclusion criteria: 1.Females who are pregnant or lactating. 2.Subjects with other active local skin diseases, such as psoriasis or herpes simplex infection in the treatment area. 3.Subjects with pre-existing scars or skin disorders in the target treatment area that may interfere with efficacy assessment, or those with active and/or non-healed wounds. 4.Subjects with a history of hypertrophic scars or keloid formation (keloid tendency). 5.Subjects with a history of severe organ dysfunction or autoimmune diseases. 6.Subjects who have participated in any other clinical trial within 30 days prior to the screening period. 7.Subjects deemed by the investigator to be unsuitable for participation in this clinical study.

Design outcomes

Primary

MeasureTime frame
Modified Stony Brook Scar Evaluation Scale;

Secondary

MeasureTime frame
Visual Analog Scale, VAS;Observer Scar Assessment Scale, OSAS;Patient Scar Assessment Scale, PSAS;

Countries

China

Contacts

Public ContactLiu Dandan

Peking University Shenzhen Hospital?

Zxwkliudandan@outlook.com+86 188 2464 6461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026